米非司酮
子宫肌瘤
医学
安慰剂
多中心研究
双盲
多中心试验
随机对照试验
妇科
泌尿科
内科学
怀孕
遗传学
生物
病理
替代医学
作者
M L Bian,M L Huang,Z Y Zhang,S M Liu,J Sun,F Fang,Y P Gu,C D Liu,C Yao
出处
期刊:PubMed
[National Institutes of Health]
日期:2021-05-25
卷期号:56 (5): 317-327
被引量:5
标识
DOI:10.3760/cma.j.cn112141-20210411-00192
摘要
Compared with placebo, oral mifepristone 10 mg/day is significantly superior to placebo in reducing the size of uterine fibroids and improving anemia, without significant adverse reactions, and could be used as a drug treatment for patients with of uterine fibroids before surgery.
科研通智能强力驱动
Strongly Powered by AbleSci AI